⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23181539 | 0.73 | RXRA (0.33) | — | |
| SCHEMBL12441005 | 0.73 | NPSR1 (0.46) | — | |
| SCHEMBL31255 | 0.72 | — | — | |
| SCHEMBL1813329 | 0.72 | NPC1 (0.37) | — | |
| SCHEMBL10021905 | 0.72 | CCR1 (0.45) | — | |
| SCHEMBL12441018 | 0.70 | UHRF1 (0.31) | — | |
| SCHEMBL3268478 | 0.69 | — | — | |
| Hydrochloric Acid SCHEMBL3269839 | 0.67 | GRM5 (0.43) | — | |
| SCHEMBL254676 | 0.67 | APLNR (0.39) | — | |
| SCHEMBL189127 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 269 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106674132-B | A kind of preparation method and application of miazines herbicide | 上海书亚医药科技有限公司 | 2019-04-26 | — | — | CN | claimed |
| CN-106674132-A | Preparation method and application of miazines herbicide | 上海书亚医药科技有限公司 | 2017-05-17 | — | — | CN | claimed |
| WO-2026103337-A1 | NOVEL SUBSTITUTED HETEROCYCLIC COMPOUND AS APELIN RECEPTOR MODULATOR | 德睿智药(苏州)新药研发有限公司 | 2026-05-21 | — | — | WO | disclosed |
| EP-4741392-A1 | 1H-PYRAZOLO[4,3-C]PYRIDINE COMPOUND, AND COMPOSITION THEREOF AND USE THEREOF | Shenzhen TargetRx Co., Ltd. (CN) | 2026-05-13 | — | — | EP | disclosed |
| US-12503473-B2 | Triazolopyrimidine compounds and their use in treating cancer | DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. (CN) | 2025-12-23 | — | — | US | disclosed |
| EP-4648853-A1 | TARGETED DEGRADATION OF VAV1 | Monte Rosa Therapeutics AG (CH) | 2025-11-19 | — | — | EP | disclosed |
| US-12466820-B2 | Amino quinazoline derivatives as P2X3 inhibitors | CHIESI FARMACEUTICI S.P.A. (IT) | 2025-11-11 | — | — | US | disclosed |
| US-12459922-B2 | PARP7 inhibitors | GILEAD SCIENCES, INC. (US) | 2025-11-04 | — | — | US | disclosed |
| US-12410210-B2 | Neuroactive steroids and their methods of use | SAGE THERAPEUTICS, INC. (US) | 2025-09-09 | — | — | US | disclosed |
| US-20250257049-A1 | HETEROCYCLIC COMPOUNDS AS MODULATORS OF MGLUR7 | PRAGMA THERAPEUTICS (FR) | 2025-08-14 | — | — | US | disclosed |
| US-20250205219-A1 | TARGETED DEGRADATION OF VAV1 | MONTE ROSA THERAPEUTICS AG (CH) | 2025-06-26 | — | — | US | disclosed |
| US-5763461-A | ANTIPICORNAVIRAL AGENTS | SANOFI (FR) | 1998-06-09 | — | — | US | disclosed |
| US-5663463-A | Difluoroethylene compounds and liquid crystal compositions containing them | ASAHI GLASS COMPANY LTD. (JP) | 1997-09-02 | — | — | US | disclosed |
| US-5618821-A | VIRICIDES, PICORNAVIRUS | SANOFI, S.A. (FR) | 1997-04-08 | — | — | US | disclosed |
| EP-0560382-B1 | Difluoroethylene compounds and liquid crystal compositions containing them | ASAHI GLASS CO LTD (JP) | 1996-07-03 | — | — | EP | disclosed |
| US-5516949-A | LOW VISCOSITY AND PHOTOSTABLE | ASAHI GLASS COMPANY LTD. (JP) | 1996-05-14 | — | — | US | disclosed |
| WO-1995031438-A1 | THERAPEUTIC PHENOXYALKYLHETEROCYCLES | SANOFI WINTHROP, INC. (US) | 1995-11-23 | — | — | WO | disclosed |
| US-5419851-A | Difluoro-derivative compounds and liquid crystal compositions containing them | ASAHI GLASS COMPANY LTD. (JP) | 1995-05-30 | — | — | US | disclosed |
| EP-0628528-A1 | DIFLUORIDE DERIVATIVE AND LIQUID CRYSTAL COMPOSITION CONTAINING THE SAME | ASAHI GLASS COMPANY LTD. (JP) | 1994-12-14 | — | — | EP | disclosed |
| EP-0560382-A1 | Difluoroethylene compounds and liquid crystal compositions containing them | ASAHI GLASS COMPANY LTD. (JP) | 1993-09-15 | — | — | EP | disclosed |